Abstract:It is recommended that a lymph node yield (LNY) of at least 12 is necessary to confirm node-negative disease for colorectal cancer. However, it is debated whether this threshold is applicable to locally advanced rectal cancer (LARC) with neoadjuvant chemoradiation (neo-CRT) and the association between LNY and survival is not clear. Some studies showed that a LNY of less than 12 was related to good tumor response. This study aimed to examine factors associated with LNY and its prognostic significance in those patients. Between 2006 and 2014, 495 LARC patients following neo-CRT and surgery were retrospectively analyzed. Clinicopathological features, overall survival (OS), disease free survival (DFS), local recurrence free survival (LRFS) and distant metastasis free survival (DMFS) were recorded. The patients were separated into two groups: LNY < 12 group and LNY ≥ 12 group. The chi-square test was used to compare differences in the distributions of the clinicopathological variables by LNY group. Univariate and multivariate analyses were performed using the Kaplan-Meier method and the Cox proportional hazards regression in all patients. Subgroup analyses were done according to status of lymph node metastasis and grade of tumor regression. Of the 495 patients, a LNY of less than 12 were found in 287 (57.98%) patients. There were no significant differences in the distributions of the clinicopathological variables by LNY group, including age, gender, distance from anus, type of surgical procedure, tumor grade, cTNM staging and ypTNM staging (all P>0.05). In addition, no association was found between LNY group and tumor regression grade (TRG) (P = 0.499). Kaplan-Meier method and univariate analysis showed that LNY ≥ 12 group had better OS (P = 0.030), DFS (P = 0.012) and DMFS (P = 0.011) compared with LNY < 12 group, but not LRFS (P = 0.293). In multivariate analysis, LNY ≥ 12 was an independent good prognostic factor of OS (HR 0.522, 95%CI 0.338-0.804, P = 0.003), DFS (HR 0.595, 95%CI 0.430-0.823, P = 0.002) and DMFS (HR 0.583, 95%CI 0.398-0.853, P = 0.005) in all patients, but not LRFS (HR 0.597, 95%CI 0.326-1.091, P = 0.093). However, subgroup analyses showed that LNY had no association with prognosis (OS, LRFS, DMFS, DFS, all P > 0.05) in patients with negative lymph nodes or patients with good tumor response (TRG = 0 and 1). Increased lymph node yield (LNY ≥ 12) was an independent good prognostic factor in locally advanced rectal cancer with neoadjuvant chemoradiation, and lower lymph node yield (LNY < 12) is not associated with good tumor response. It indicates that these patients probably still need enough number of lymph node yield (≥ 12) even though they received neoadjuvant chemoradiation.

Cross-sectional investigation of the distribution characteristics and prognostic significance of lateral lymph nodes in patients with rectal cancer

Contrast-enhanced CT Imaging for the Assessment of Lymph Node Status in Patients with Colorectal Cancer

Effect of Lateral Lymph Nodes Without Malignant Characteristics on the Prognosis of Patients with Rectal Cancer.

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China

Examined Lymph Node Numbers Influence Prognosis in Rectal Cancer Treated with Neoadjuvant Therapy

Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Lateral lymph node metastasis without mesenteric lymph node involvement in middle-low rectal cancer: Results of a multicentre lateral node collaborative group study in China

Prognostic Value of Lymph Node Yield in Locally Advanced Rectal Cancer with Neoadjuvant Chemoradiotherapy.

Good Prognostic Value of Increased Lymph Node Yield in Locally Advanced Rectal Cancer with Neoadjuvant Chemoradiotherapy

To Be or Not to Be: Significance of Lymph Nodes on Pretreatment CT in Predicting Survival of Rectal Cancer Patients

Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes

Short-term outcomes of 47 selective laparoscopic lymph node dissection for rectal cancer: A retrospective study

Imaging diagnostic value of lateral lymph node metastasis in middle and low rectal cancer

Increased Lymph Node Yield Indicates Improved Survival in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy

[Analysis of Prognostic Factors in Patients with Lymph Node-Negative Rectal Cancer].

[Lateral Pelvic Lymph Node Metastasis is an Important Prognostic Factor for Low Rectal Cancer].

Lateral lymph node dissection can increase overall survival and 5‐year survival rate of rectal cancer patients: A meta‐analysis

Prognostic value of lateral lymph node metastasis in pretreatment MRI for rectal cancer in patients undergoing neoadjuvant chemoradiation followed by surgical resection without lateral lymph node dissection: A systemic review and meta-analysis